236 related articles for article (PubMed ID: 32565980)
1. Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer.
Yanai Y; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Yao T; Saito T
Oncol Lett; 2020 Jul; 20(1):541-550. PubMed ID: 32565980
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular features between synchronous and metachronous metastases in colorectal cancer.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
Am J Cancer Res; 2021; 11(4):1646-1658. PubMed ID: 33948379
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
4. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
6. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
7. Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgery.
Schweiger T; Liebmann-Reindl S; Glueck O; Starlinger P; Laengle J; Birner P; Klepetko W; Pils D; Streubel B; Hoetzenecker K
J Thorac Dis; 2018 Nov; 10(11):6147-6157. PubMed ID: 30622786
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
9. Molecular spectrum of
Al-Shamsi HO; Jones J; Fahmawi Y; Dahbour I; Tabash A; Abdel-Wahab R; Abousamra AO; Shaw KR; Xiao L; Hassan MM; Kipp BR; Kopetz S; Soliman AS; McWilliams RR; Wolff RA
J Gastrointest Oncol; 2016 Dec; 7(6):882-902. PubMed ID: 28078112
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
11. Gene heterogeneity in metastasis of colorectal cancer to the lung.
Hou J; Zhang Y; Zhu Z
Semin Cell Dev Biol; 2017 Apr; 64():58-64. PubMed ID: 27590223
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody.
Adua D; Di Fabio F; Ercolani G; Fiorentino M; Gruppioni E; Altimari A; Rojas Limpe FL; Normanno N; Pinna AD; Pinto C
Mol Clin Oncol; 2017 Jul; 7(1):113-120. PubMed ID: 28685087
[TBL] [Abstract][Full Text] [Related]
13. Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.
Iwasaki A; Shirakusa T; Yamashita Y; Noritomi T; Maekawa T; Hamada T
Thorac Cardiovasc Surg; 2005 Dec; 53(6):358-64. PubMed ID: 16311973
[TBL] [Abstract][Full Text] [Related]
14. Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases.
Song Y; Wang L; Ran W; Li G; Xiao Y; Wang X; Zhang L; Xing X
Front Genet; 2020; 11():96. PubMed ID: 32161617
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract][Full Text] [Related]
16. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
[TBL] [Abstract][Full Text] [Related]
18. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
[TBL] [Abstract][Full Text] [Related]
19. Effect of
Chuang SC; Huang CW; Chen YT; Ma CJ; Tsai HL; Chang TK; Su WC; Hsu WH; Kuo CH; Wang JY
Oncol Lett; 2020 Sep; 20(3):2119-2130. PubMed ID: 32782529
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
